Tag Archives: Rapid Screening

Blood Test Able to Predict Alzheimer’s Disease Decades Before Symptoms? (BBC News / Neurology)

Posted on August 3, 2019 by Dementia and Elderly Care News

Summary Research published in the Neurology journal claims a significant breakthrough in the development of a blood test (for plasma Aβ42/Aβ40) which may be able to predict Alzheimer’s Disease onset with 94% accuracy. Due caution: “But it’s important to note … Continue reading →

Posted in BBC News, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Quick Insights, Universal Interest | Tagged Alzheimer's Disease: Diagnosis, Alzheimer’s Early Screening, Amyloid, Amyloid and Tau PET, Amyloid Beta, Amyloid Beta (Aβ42 and Aβ40), Amyloid Beta Protein, Amyloid-β (Aβ), Amyloid-β Protein, BBC Health News, Biomarkers, Biomarkers Predicting Cognitive Decline and Alzheimer's Disease, Blood Proteins as Biomarkers of Disease Research, Blood Test for Brain Amyloidosis: Validated Using Amyloid PET and CSF p-tau181/Aβ42 as Reference Standards, Blood Tests, Blood-Based Biomarkers, Blood-Based Biomarkers of Pre-Symptomatic Alzheimer’s Disease, Brain Imaging, Brain Research, Case Finding, Conversion to Dementia From Prodromal Disease, Dementia Diagnosis, Dementia Innovation, Dementia Research, Dementia Screening, Department of Neurology: Washington University, Diagnosis, Diagnosis of Alzheimer's Disease, Diagnostic Imaging, Division of Biostatistics: Washington University, Drug Development for Alzheimer's Disease, Early Detection of Preclinical Disease, Early Diagnosis, Early Diagnosis of Alzheimer's Disease, Hope Center for Neurological Disorders: Washington University, Knight Alzheimer's Disease Research Center: Washington University, Mallinckrodt Institute of Radiology: Washington University, Neurology (Journal), Non-Invasive Biomarkers, Plasma Biomarkers, Plasma β-Amyloid 42/40, Plasma Protein Markers of MRI Measures in Asymptomatic Individuals, Preclinical Alzheimer's Disease, Preclinical Biomarkers in Alzheimer's Disease, Predictive Ability (of Tests), Prodromal Alzheimer's Disease, Protein-Based Biomarkers in Blood May Deliver Accurate Diagnoses, Rapid Screening, Recruitment Onto Dementia Clinical Trials, SAP (Protein), SAP: Serum Amyloid Protein, Screening, Screening for Dementia, Washington University School of Medicine | Leave a comment

Dementia Biomarkers Re-Explored? (General Psychiatry / JGCR)

Posted on June 17, 2019 by Dementia and Elderly Care News

Summary A recent systematic review examines biomarkers, as strictly defined, for neurodegenerative diseases. “Vast improvements in neuroimaging techniques have led to newly discovered biomarkers and diagnostics”. p.5 Behavioural biomarkers are mentioned hardly at all. Full Text Link Reference Maclin, JMA. … Continue reading →

Posted in Alzheimer’s Research UK, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Mental Health, Personalisation, Quick Insights, Systematic Reviews, UK, Universal Interest | Tagged 18F-florbetaben, 18F-flutemetamol, 18Fflorbetapir, Alzheimer's Disease: Diagnosis, Alzheimer’s Disease, Alzheimer’s Disease and Dementia, Alzheimer’s Disease Biomarkers, Alzheimer’s Research UK (ARUK), Amyloid and Tau PET, APOE e4 (Apolipoprotein E e4), Apolipoprotein E (APOE) e4 Allele, Behavioural Biomarkers, Beta-Amyloid PET Imaging, Biomarker Development, Biomarkers, Biomarkers Predicting Cognitive Decline and Alzheimer's Disease, Canonical Syndromes of Primary Progressive Aphasia: Non-Fluent / Agrammatic Variant (nfvPPA), Canonical Syndromes of Primary Progressive Aphasia: Semantic Variant (svPPA), Carbon-11 Pittsburgh Compound-B (C-PIB) Radioisotope Tracer, Cerebral Metabolic Rate for Glucose (CMRgl), Cerebrospinal Fluid (CSF) Biomarkers, Cerebrospinal Fluid and Serum MHPG, CMRgl Decline, Corticobasal Degeneration (CBD), CSF 3-methoxy-4-hydrox-yphenylglycol (MHPG), Dementia With Lewy Bodies (DLB), Differential Diagnosis, DLB: Dementia with Lewy Bodies, Docosahexaenoic Acid (DHA), Early Diagnosis, Early Diagnosis of Alzheimer's Disease, Eicosapentaenoic Acid (EPA), Frontotemporal Dementia (FTD), α-Synuclein, Journal of Geriatric Care and Research (JGCR), Lewy Body Dementia (LBD), Magnetic Resonance Imaging (MRI), Medial Temporal Lobe Atrophy (MTA), Medial Temporal Lobes (MTL), Metabolic Syndrome (MetS), MRI Brain Imaging, Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neuroimaging, Neuroimaging in Dementia Diagnosis, Non-Invasive Biomarkers, Pick’s Disease (Frontotemporal Dementia), Positron Emission Tomography (PET), Preclinical Alzheimer's Disease, Primary Progressive Aphasia (PPA), Progressive Supranuclear Palsy (PSP), Rapid Screening, Screening for Dementia, Sea Hero Quest (SHQ) Game, Sea Hero Quest VR, Tau PET, Timely Diagnosis, VaD: Vascular Dementia, Variants of Primary Progressive Aphasia (PPA), Vascular Dementia, [18F]THK5351 | Leave a comment

Smell Test for Early Detection of Parkinson’s Disease (BBC News)

Posted on March 21, 2019 by Dementia and Elderly Care News

Summary Parkinson’s Disease has a distinctive odour for certain gifted individuals, which has been analysed chemically and may now be replicated for automated detection by machine. This may, in future, permit earlier diagnosis and open the possibilities for timely treatments … Continue reading →

Posted in BBC News, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Parkinson's Disease, Quick Insights, Scotland, UK, Universal Interest | Tagged ACS Central Science (Journal), Anatune (Cambridge UK), BBC Health News, BBC Scotland News, Biomarkers, Biomarkers Predicting Parkinson's Disease, Department of Biochemistry: University of Liverpool, Department of Neurology: Salford Royal Foundation Trust, Early Diagnosis, Early Diagnosis of Parkinson’s Disease, Edinburgh University, Eicosane, Hyperosmic Super Smeller, Institute for Stem Cell Research: University of Edinburgh, Institute of Integrative Biology: University of Liverpool, Joy Milne, Les Milne, Manchester Academic Health Science Centre: University of Manchester, Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Non-Invasive Biomarkers, Odour, Parkinson's Disease Smell Test, Parkinson’s Disease Sebum Volatilome, Parkinson’s UK, Perillic Aldehyde, Rapid Screening, Salford Royal Foundation Trust, School of Biological Sciences: University of Edinburgh, Sebum, Smell Test for Parkinson's Disease Diagnosis, Timely / Preclinical Parkinson's Disease Diagnosis, Timely Diagnosis, University of Edinburgh, University of Liverpool, University of Manchester, Volatile Biomarkers of Parkinson’s Disease, Volatilome | Leave a comment

Eye Tests for Early Detection of Alzheimer’s Disease? (NHS Digital / Ophthalmology Retina)

Posted on March 20, 2019 by Dementia and Elderly Care News

Summary Further discussion about the possibilities of using inexpensive eye tests to detect Alzheimer’s Disease, perhaps years before symptoms appear. This particular technique involves the examination of blood vessels and blood flow in the retina, as detected by Octa (Optical … Continue reading →

Posted in Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Quick Insights, Universal Interest | Tagged Alzheimer's Disease: Diagnosis, Alzheimer’s Disease, Alzheimer’s Disease and Dementia, Alzheimer’s Disease Biomarkers, Assessment and Diagnosis, Bazian, Behind the Headlines, Biomarkers, Biomarkers Predicting Cognitive Decline and Alzheimer's Disease, Central Subfield Thickness (CST), Cognitive Impairment, Critical Appraisals, Dementia Case Finding, Dementia Diagnosis, Dementia Screening, Diagnosis, Diagnosis of Alzheimer's Disease, Diagnostics, Duke University in North Carolina, Early Diagnosis, Early Diagnosis of Alzheimer's Disease, Early Treatment Diabetic Retinopathy Study, Eye Examinations, Foveal Avascular Zone (FAZ) Area, Karen L. Wrenn Alzheimer's Disease Award, Macular Ganglion Cell-Inner Plexiform Layer (GC-IPL), MCI: Mild Cognitive Impairment, Mild Cognitive Impairment, National Institutes of Health, National Institutes of Health (NIH), National Institutes of Health (US), Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, NHS Digital (Formerly NHS Choices), Non-Invasive Biomarkers, Octa: Optical Coherence Tomography Angiography, Ophthalmology Retina, Optical Coherence Tomography, Optical Coherence Tomography Angiography (OCTA), Preclinical Alzheimer's Disease, Rapid Screening, Research to Prevent Blindness Inc. (New York), Retina as Early Biomarker of Neurodegeneration, Retinal Biomarkers, Retinal Examination in Neurodegenerative Diseases, Retinal Microvascular and Neurodegenerative Changes in Alzheimer’s Disease, Retinal Microvascular and Neurodegenerative Changes in Mild Cognitive Impairment, Retinal Vessel Density (VD), Screening, Screening for Dementia, Timely Diagnosis, US National Institutes of Health (NIH), USA | Leave a comment

Screening For Frailty: as Easy as eFI? (NHS England / Age and Ageing)

Posted on September 20, 2016 by Dementia and Elderly Care News

Summary The “electronic Frailty Index (eFI)” is discussed, by NHS England’s National Clinical Director for Older People and Person Centred Integrated Care, as a validated tool which might assist in the proactive identification, diagnosis and management of frailty. Potentially, the … Continue reading →

Posted in Commissioning, Community Care, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, Management of Condition, National, NHS, NHS England, Non-Pharmacological Treatments, Person-Centred Care, Quick Insights, Statistics, Systematic Reviews, UK, Universal Interest | Tagged Academic Unit of Elderly Care and Rehabilitation: University of Leeds, Age and Ageing, Ageing and Long-Term Care: Projections, Ageing Population, Ageing Research, Amenable Mortality, Avoidable Hospital Admissions, Avoidable Mortality, Avoidable Premature Mortality, Avoidable Rehospitalisations, BMJ Open, BMJ Publishing Group Ltd, Bradford, British Geriatrics Society, Care for Vulnerable Older People, Care Home Admission Delay, Care of Frail Older People With Complex Needs, Centre for Reviews and Dissemination: University of York, Charlson Comorbidity Index, Commissioning for Older People, Connected Bradford, Connected Health Cities, Count-Based Multimorbidity Measures, Cumulative Deficit Frailty Model, Cumulative Deficit Model, Deficits Contained in eFI Calculations, Disease Counts, Dr Martin Vernon: Consultant Geriatrician and Associate Head of Division for Medicine and Community Services for Central Manchester, Dr Martin Vernon: National Clinical Director for Older People and Integrated Care, Dr Martin Vernon: NCD for Older People and Integrated Person Centred Care, Dublin, Effectiveness Matters, Electronic Frailty Index, electronic Frailty Index (eFI), Electronic Health Records, Electronic Health Records (EHRs), Faculty of Health Studies: University of Bradford, Frail Older People, Frailty, Frailty Identification and Frailty Care, Frailty Services, Frailty Syndromes, Functional Decline, General Practice, General Practices, General Practitioners, GP Assessment, Guidance on Supporting Routine Frailty Identification and Frailty Care Through the GP Contract 2017/2018, Holistic Medical Reviews (Automated Electronic Heuristics), Holistic Medical Reviews by GPs, HRB Centre for Primary Care Research: Royal College of Surgeons in Ireland (RCSI), Identification of Frailty, Identification of Frailty (Routine Screening), Identifying People Living With Frailty, Identifying Vulnerable People, Improving Care for Frail Older People, Improving General Practice, Improving Quality in General Practice, Improving the Quality of Care in General Practice, Inappropriate Hospital Admissions, Independence at Home, Institute of Applied Health Research: University of Birmingham, Ireland, John Young: Academic Unit of Elderly Care and Rehabilitation at University of Leeds, Long-Term Care and Support, Long-Term Conditions (LTCs), Maintaining Independence, Medication Counts, Mortality in Older People, Mortality Morbidity and Wellbeing, Multimorbidity Measures, Older Community-Dwelling Adults, Older People At Home, Opportunities to Treat Patients Without Hospital Admission, Pathways for Frail and Vulnerable People, People Living With Frailty, Point-of-Care Screening, Population Health Sciences Division: Royal College of Surgeons of Ireland (RCSI), Preventable Hospital Admissions, Primary Care, Professor John Young, Professor John Young: Former National Clinical Director for Integration and Frail Elderly at NHS England, Rapid Screening, Recognising and Managing Frailty in Primary Care, Reducing Unplanned Hospitalisation, Rehospitalisations, ResearchOne (TPP Leeds West Yorkshire), ResearchOne Health and Care Database, ResearchOne Primary Care Database, Risk of Nursing Home Admission, Routine Primary Care Electronic Health Record Data, Royal College of Surgeons of Ireland (RCSI), RxRisk-V, Screening, Screening For Frailty, Screening Tests, Selected Conditions Counts, Shakespeare: Seven Ages of Man, Staying Independent, Supporting Older People Living With Frailty in the Community, Supporting People With Hospital Admissions, Supporting Vulnerable People, SystmOne (TPP Leeds West Yorkshire), SystmOne Electronic Health Record System, Targeted Screening, Targeting Resources on Vulnerable Populations, The Health Improvement Network (THIN) Databases, THIN Database, Toolkit for General Practice in Supporting Older People Living With Frailty (NHS England), TPP SystmOne Clinical System, Treating Patients Without Hospital Admission, University of Leeds, University of York, Unnecessary Hospital Admissions, Unplanned Hospital Admissions, Unplanned Hospitalisation, Validation of electronic Frailty Index (eFI), Vulnerable Adults, West Yorkshire, Yorkshire and Humber AHSN Improvement Academy | Leave a comment

Blood Test Potentially Able to Predict Alzheimer’s Disease Onset (BBC News / Alzheimer’s & Dementia)

Posted on July 8, 2014 by Dementia and Elderly Care News

Summary Research published in the Alzheimer’s & Dementia: the Journal of the Alzheimer’s Association may indicate a significant step forwards in developing a blood test which could be able to predict the risk of Alzheimer’s Disease onset with 87% accuracy. Research … Continue reading →

New Blood Test May Predict Alzheimer’s Disease Onset (BBC News / NHS Choices / Nature Medicine)

Posted on March 10, 2014 by Dementia and Elderly Care News

Summary Researchers at Georgetown University in Washington DC claim to have devised a new blood test which promises to be able to predict the risk of Alzheimer’s Disease onset with 90% accuracy. The test is based on the levels of 10 … Continue reading →

Posted in BBC News, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Quick Insights, Universal Interest | Tagged Alzheimer's Disease: Diagnosis, Alzheimer’s Early Screening, Amnestic Mild Cognitive Impairment (aMCI), Assessment and Diagnosis, BBC Health News, Biomarkers, Biomarkers Predicting Cognitive Decline and Alzheimer's Disease, Blood Tests, Blood-Based Biomarkers, Case Finding, Cell Membrane Integrity, Cognitive Decline Studies, Cognitive Impairment, Dementia Case Finding, Dementia Diagnosis, Dementia Screening, Diagnosis, Diagnosis of Alzheimer's Disease, Diagnostics, Differential Diagnosis, Early Detection of Preclinical Disease, Early Diagnosis, Early Diagnosis of Alzheimer's Disease, Early Differential Diagnosis, Early Screening, Georgetown University, Georgetown University Medical Center, Georgetown University Medical Center (GUMC), Late-Life Cognitive Decline, Lipids, MCI: Mild Cognitive Impairment, Mild Cognitive Impairment (MCI), National Institutes of Health (NIH), National Institutes of Health (US), Nature Medicine, Non-Invasive Biomarkers, Plasma Phospholipids, Preclinical Alzheimer's Disease, Rapid Screening, Screening, Screening for Dementia, Screening Tools for Amnestic Mild Cognitive Impairment (a-MCI), United States, Unity Health System: Rochester (USA), University of California: Irvine School of Medicine, USA | Leave a comment

Self-Administered Gerocognitive Examination (SAGE) for Community Cognitive Screening? (NHS Choices / Journal of Neuropsychiatry and Clinical Neurosciences)

Posted on January 20, 2014 by Dementia and Elderly Care News

Summary A US study involving 1,047 people over the age of 50 assessed the Self-Administered Gerocognitive Examination (SAGE) test as a potential screening tool for mental decline. It was found that this simple and inexpensive pencil and paper test could … Continue reading →

Posted in Community Care, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Patient Information, Quick Insights, Universal Interest | Tagged Alzheimer’s Early Screening, Assessment and Diagnosis, Behind the Headlines, Case Finding, Case Finding for Patients with Dementia, Cognitive Impairment, Cognitive Screening, Cognitive Screening Instruments, Community Cognitive Screening, Critical Appraisals, Dementia Case Finding, Dementia Screening, Dementia Screening Debate, Diagnosis and Assessment, Diagnosis and Referral, Dot-to-Dot Tests, Early Diagnosis, Early Screening, Executive Skills, Journal of Neuropsychiatry and Clinical Neurosciences, Language Skills (Verbal Fluency and Picture Naming), Memory, Memory Loss, Memory Problems, Mild Cognitive Impairment (MCI), Ohio State University Wexner Medical Center, Orientation Skills, Prevalence of Cognitive Impairment, Problem-Solving Skills, Rapid Screening, Reasoning and Computation Skills, SAGE Test, Screening, Screening for Dementia, Self-Administered Gerocognitive Examination (SAGE), Timely Diagnosis, Trail Making Test-B, Visuospatial Skills (3D Construction and Clock-Drawing), Wexner Medical Center: Ohio State University | Leave a comment

Blood Test for Early Detection of Alzheimer’s Disease? (BBC News / Genome Biology)

Posted on July 30, 2013 by Dementia and Elderly Care News

Summary The degenerative processes causing Alzheimer’s Disease are believed to start often years before clinical symptoms become apparent. Researchers have been investigating ways of detecting the disease earlier. Such tests should help in learning more about how the disease progresses. Tests … Continue reading →

Blood Test Could Assist Early Diagnosis of Alzheimer’s Disease (BBC News)

Posted on March 11, 2013 by Dementia and Elderly Care News

Summary Researchers at the University of Nottingham are developing a quick and easy blood test to detect proteins linked strongly with Alzheimer’s Disease, such as amyloid and APOE, in combination with other markers linked to inflammation. The test has not been fully validated yet, and could be … Continue reading →

Posted in Acute Hospitals, Alzheimer’s Research UK, BBC News, Community Care, Diagnosis, For Researchers (mostly), In the News, Quick Insights, UK, Universal Interest | Tagged Alzheimer's Gene (APOE4 Gene), Alzheimer’s Early Screening, Amyloid Beta, Amyloid Beta (Aβ42 and Aβ40), Amyloid Beta Protein, Amyloid-β (Aβ), APOE, ApoE and Genetics of Alzheimer's Disease, ApoE e4 Allele, APOE4 Gene, Apolipoprotein E (APOE) e4 Allele, BBC Health News, Beta-Amyloid, Beta-Amyloid Plaques, Biomarkers, Blood Tests, Case Finding for Patients with Dementia, Common Genetic Risk Factor Links Alzheimer’s Disease and Type 2 Diabetes (SorCS1), Dementia Case Finding, Diagnostic Markers, Early Diagnosis, Early Diagnosis of Alzheimer's Disease, Early Screening, Effective Diagnostics, Genetic Profiling, Genetics of Alzheimer's Disease, Inflammation, β-amyloid, Nottingham Trent University’s John van Geest Cancer Research Centre, Rapid Screening, Screening, Screening for Dementia, Targeted Screening for Dementia, University of Nottingham, University of Nottingham’s School of Molecular Medical Sciences | Leave a comment

Tag Archives: Rapid Screening

Blood Test Able to Predict Alzheimer’s Disease Decades Before Symptoms? (BBC News / Neurology)

Dementia Biomarkers Re-Explored? (General Psychiatry / JGCR)

Smell Test for Early Detection of Parkinson’s Disease (BBC News)

Eye Tests for Early Detection of Alzheimer’s Disease? (NHS Digital / Ophthalmology Retina)

Blood Test Potentially Able to Predict Alzheimer’s Disease Onset (BBC News / Alzheimer’s & Dementia)

New Blood Test May Predict Alzheimer’s Disease Onset (BBC News / NHS Choices / Nature Medicine)

Blood Test for Early Detection of Alzheimer’s Disease? (BBC News / Genome Biology)

Blood Test Could Assist Early Diagnosis of Alzheimer’s Disease (BBC News)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites